Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

(2017) Christian Uprimny et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

68Ga-PSMA ligand PET/CT in patients with prostate cancer: First experience

(2017) A. Freimanis et al.   EUROPEAN UROLOGY SUPPLEMENTS

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning

(2017) Jeremie Calais et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging Neurotensin Receptor in Prostate Cancer With 64Cu-Labeled Neurotensin Analogs

(2017) Huaifu Deng et al.   Molecular Imaging

Expression of prostate-specific membrane antigen (PSMA) on circulating tumor cells (CTCs) in castration-resistant prostate cancer.

(2017) Florence Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Preclinical Study on GRPR-Targeted 68Ga-Probes for PET Imaging of Prostate Cancer

(2016) Yao Sun et al.   BIOCONJUGATE CHEMISTRY

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake

(2016) N. Pandit-Taskar et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical Translation of a Dual Integrin α v β 3 – and Gastrin-Releasing Peptide Receptor–Targeting PET Radiotracer, 68 Ga-BBN-RGD

(2016) Jingjing Zhang et al.   JOURNAL OF NUCLEAR MEDICINE

Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer

(2016) Said M. Elshafae et al.   PROSTATE

PSMA PET and Radionuclide Therapy in Prostate Cancer

(2016) Kirsten Bouchelouche et al.   SEMINARS IN NUCLEAR MEDICINE

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

(2015) Jonathan I. Epstein et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT

(2015) Theodosia Maina et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor

(2015) Huaifu Deng et al.   MOLECULAR PHARMACEUTICS

Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging

(2015) Levent Kabasakal et al.   NUCLEAR MEDICINE COMMUNICATIONS

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy

(2014) Maxim Rybalov et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Facile Preparation of a Thiol-Reactive 18F-Labeling Agent and Synthesis of 18F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor

(2014) Z. Wu et al.   JOURNAL OF NUCLEAR MEDICINE

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors

(2014) C. Morgat et al.   JOURNAL OF NUCLEAR MEDICINE

The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4–10 ng/mL

(2013) C. F. Ng et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation

(2011) N. C. K. Valerie et al.   CANCER RESEARCH

Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates

(2011) Marc Beer et al.   PROSTATE

Altered Expression of Neurotensin Receptors Is Associated with the Differentiation State of Prostate Cancer

(2010) S. L. Swift et al.   CANCER RESEARCH

Nerve growth factor signaling in prostate health and disease

(2010) Nicola Arrighi et al.   GROWTH FACTORS